My spin;
1. Research interest in peptide libraries was getting so big they had to set up the Cambridge option.
2.Big Pharma patent expiry cliff/lack of blockbuster drugs- already well known providing external opportunities with companies like PYC.
3. Billions of "options" generated a process to speed up analysis from years to weeks.
4.New Discussions gathering momentum- anyone know which Pharma Company based in La Jolla, San Diego - sounds like clue.
Might have been a good decision to buy PYCO this morning. Sounds like a break out year 2011.
Thoughts everyone?
Ramses
a good company update, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $184.4K | 1.756M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 299175 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1884388 | 8 |
View Market Depth
| Last trade - 13.55pm 21/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |